References:

[1] Atkins RC, Zimmet P. Diabetic kidney disease: act now or pay later[ J] . Kidney Int,2010,77( 5) :375 -377.
[2] DoshiSM, FriedmanAN. Diagnosis and Management of Type 2 Diabetic Kidney Disease[ J] . Clin J Am Soc Nephrol,2017,12( 8) :1366 -1373.
[3]闫凯,温乔,谢璇,等.王暴魁“清热凉血”法治疗糖尿病肾病经验介绍[J].环球中医药,2017,10(6):712-713.
[4]中华医学会糖尿病学分会微血管并发症学组.糖尿病肾病防治专家共识(2014年版)[J].中华糖尿病杂志,2014,6(11):792-801.
[5]中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:147,150-151.
[6]中华医学会糖尿病学分会.中国2型糖尿病防治指南(2017年版)[J].中国实用内科杂志,2018,38(4):292-344.
[7]中华中医药学会肾病分会.糖尿病肾病诊断?辨证分型及疗效评定标准(试行方案)[J].上海中医药杂志,2007,41(7):7-8.
[8] ChangAS, Hathaway C K, SmithiesO, etal. Transforming growth factor - β1 and diabetic nephropathy[ J] . Am J Physiol Renal Physiol,2016,310( 8) :689- 696.
[9] Zhou T B, Li H Y, Zhong H Z, etal. Relationship between transforming growth factor - β1 and type 2 diabetic nephropathy risk in Chinese population[ J] . BMC Med Genet. 2018,19:201.
[10] Brou N A, Jacqz - Aigrain E, Wei Zhao. Cystatin C as a potential biomarker for dosing of renally excreted drugs [ J] . Br J Clin Pharmacol,2015,80( 1) :20 ? 27.
[11]吴宏辉,郭晓媛,谢璇,等.王暴魁教授糖尿病肾病“消渴热”病机理论初探[J].环球中医药,2019,12(2):210-213.
[12]严倩华,邹燕勤.国医大师邹燕勤教授从脾肾论治糖尿病肾病[J].南京中医药大学学报,2018,34(2):109-111.
[13]姬玉,杨芳,马莉莎,等.解毒法治疗糖尿病肾病的探究[J].现代中医药,2018,38(4):81-83.